TY - JOUR
T1 - Reverse Transcription Loop-Mediated Isothermal Amplification Assay for Ultrasensitive Detection of SARS-CoV-2 in Saliva and Viral Transport Medium Clinical Samples
AU - Ganguli, Anurup
AU - Mostafa, Ariana
AU - Berger, Jacob
AU - Lim, Jongwon
AU - Araud, Elbashir
AU - Baek, Janice
AU - Stewart de Ramirez, Sarah A
AU - Baltaji, Ali
AU - Roth, Kelly
AU - Aamir, Muhammad
AU - Aedma, Surya
AU - Mady, Mohamed
AU - Mahajan, Pranav
AU - Sathe, Sanjivani
AU - Johnson, Mark
AU - White, Karen
AU - Kumar, James
AU - Valera, Enrique
AU - Bashir, Rashid
N1 - Funding Information:
The following reagents were obtained through BEI Resources, NIAID, NIH: (i) genomic RNA from Zika Virus, PRVABC59, NR-50244; (ii) Zika Virus, PRVABC59, NR-50240. The following reagents were deposited by the Centers for Disease Control and Prevention and obtained through BEI Resources, NIAID, NIH: (i) genomic RNA from SARS-related coronavirus 2, isolate USA-WA1/2020, NR-52285; (ii) SARS-related coronavirus 2, isolate USA-WA1/2020, heat-inactivated, NR-52286. The authors thank the staff at the Holonyak Micro and Nanotechnology Laboratory at UIUC for facilitating the research and the funding from University of Illinois. R.B. and E.V. acknowledge support of NIH R21 AI146865A and also to support A.G. A.M. was partially supported by a cooperative agreement with Purdue University and the Agricultural Research Service of the United States Department of Agriculture, AG Sub Purdue 8000074077 to R.B. R.B. and E.V. acknowledge the support of NSF Rapid Response Research (RAPID) grant (award 2028431). R.B., E.V., A.G., and S.A.S.d.R. acknowledge the support of the Jump Applied Research through Community Health through Engineering and Simulation (ARCHES) endowment through the Health Care Engineering Systems Center at the UIUC. The authors thank Sara Riggenbach, Gabriel Koch, and Bill Bond of OSH Healthcare (Peoria, IL) for their support of the IRB # 1602513 and patient sample acquisition for this study. We also thank Mary Ellen Sherwood, Reubin McGuffin, and Carly Skadden of Carle Foundation Hospital (Urbana, IL) for their support of the IRB # 20CRU3150 and patient sample acquisition for this study.
Publisher Copyright:
© 2021 American Chemical Society. All rights reserved.
PY - 2021/6/8
Y1 - 2021/6/8
N2 - The COVID-19 pandemic has underscored the shortcomings in the deployment of state-of-the-art diagnostics platforms. Although several polymerase chain reaction (PCR)-based techniques have been rapidly developed to meet the growing testing needs, such techniques often need samples collected through a swab, the use of RNA extraction kits, and expensive thermocyclers in order to successfully perform the test. Isothermal amplification-based approaches have also been recently demonstrated for rapid severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) detection by minimizing sample preparation while also reducing the instrumentation and reaction complexity. In addition, there are limited reports of saliva as the sample source, and some of these indicate inferior sensitivity when comparing reverse transcription loop-mediated isothermal amplification (RT-LAMP) with PCR-based techniques. In this paper, we demonstrate an improved sensitivity assay from saliva using a two-step RT-LAMP assay, where a short 10 min RT step is performed with only B3 and backward inner primers before the final reaction. We show that while the one-step RT-LAMP demonstrates satisfactory results, the optimized two-step approach allows detection of only few molecules per reaction and performs significantly better than the one-step RT-LAMP and conventional two-step RT-LAMP approaches with all primers included in the RT step. We show control measurements with RT-PCR, and importantly, we demonstrate RNA extraction-free RT-LAMP-based assays for detection of SARS-CoV-2 from viral transport media and saliva clinical samples.
AB - The COVID-19 pandemic has underscored the shortcomings in the deployment of state-of-the-art diagnostics platforms. Although several polymerase chain reaction (PCR)-based techniques have been rapidly developed to meet the growing testing needs, such techniques often need samples collected through a swab, the use of RNA extraction kits, and expensive thermocyclers in order to successfully perform the test. Isothermal amplification-based approaches have also been recently demonstrated for rapid severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) detection by minimizing sample preparation while also reducing the instrumentation and reaction complexity. In addition, there are limited reports of saliva as the sample source, and some of these indicate inferior sensitivity when comparing reverse transcription loop-mediated isothermal amplification (RT-LAMP) with PCR-based techniques. In this paper, we demonstrate an improved sensitivity assay from saliva using a two-step RT-LAMP assay, where a short 10 min RT step is performed with only B3 and backward inner primers before the final reaction. We show that while the one-step RT-LAMP demonstrates satisfactory results, the optimized two-step approach allows detection of only few molecules per reaction and performs significantly better than the one-step RT-LAMP and conventional two-step RT-LAMP approaches with all primers included in the RT step. We show control measurements with RT-PCR, and importantly, we demonstrate RNA extraction-free RT-LAMP-based assays for detection of SARS-CoV-2 from viral transport media and saliva clinical samples.
KW - COVID-19
KW - severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
KW - Pandemic
KW - Coronavirus
KW - Novel coronavirus
KW - 2019-nCoV
UR - http://www.scopus.com/inward/record.url?scp=85108340612&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85108340612&partnerID=8YFLogxK
U2 - 10.1021/acs.analchem.0c05170
DO - 10.1021/acs.analchem.0c05170
M3 - Article
C2 - 34033472
SN - 0003-2700
VL - 93
SP - 7797
EP - 7807
JO - Analytical Chemistry
JF - Analytical Chemistry
IS - 22
ER -